Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01104402 · ClinicalTrials.gov registry record · NA
Early Intervention in Cystic Fibrosis Exacerbation
A NA study of Cystic Fibrosis, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 267
- Enrollment target
- 3
- Study locations
NCT01104402 is a NA study of Cystic Fibrosis that has completed, run by Johns Hopkins University. The registered enrollment target is 267 participants, above the 178-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (50% higher). The trial reports 3 study locations across 2 states.
The verdict
NCT01104402, a NA study of Cystic Fibrosis, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 267 participants
- Enrollment target
- 3
- Study locations
Study Summary
Individuals with cystic fibrosis (CF) develop chronic lung infections and suffer intermittent acute exacerbations of their lung disease. Most exacerbations are not treated until they cause increased symptoms, and patients seek medical attention. This proposal details a study of home lung function and symptom monitoring. Subjects will be randomly assigned to one of two groups: 1) home monitoring, in which spirometry and symptoms are recorded; or 2) standard care. The home monitoring data will be transmitted electronically to the study center. If spirometry or symptoms have deteriorated substantially, treatment for a CF pulmonary exacerbation will be initiated. It is anticipated that use of home monitoring will lead to earlier, more reliable recognition and treatment of exacerbations, which will translate into better lung health.
Conditions Studied
Interventions
- DEVICE Home lung function and symptom monitoring
Study Locations (3)
Washington
- University of Washington - Seattle
- Seattle Children's Hospital - Seattle
Maryland
- Johns Hopkins University CF Clinic - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 267 participants |
| Start Date | 2011-10 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01104402
The ClinicalTrials.gov registry entry for NCT01104402 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 267 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 178-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (50% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cystic Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which Home lung function and symptom monitoring is the first listed.
NCT01104402 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Washington, Maryland.
Frequently Asked Questions
What is clinical trial NCT01104402 about?
NCT01104402 is a clinical study titled "Early Intervention in Cystic Fibrosis Exacerbation". Individuals with cystic fibrosis (CF) develop chronic lung infections and suffer intermittent acute exacerbations of their lung disease. Most exacerbations are not treated until they cause increased symptoms, and patients seek medical attention. This proposal details a study of home lung function an...
What is the current status of trial NCT01104402?
This trial is currently completed. It is a NA study. The enrollment target is 267 participants. The study started on 2011-10. Estimated completion is 2015-09.
What conditions does trial NCT01104402 study?
This clinical trial studies the following conditions: Cystic Fibrosis.
What interventions are being tested in trial NCT01104402?
The interventions under investigation include: Home lung function and symptom monitoring (DEVICE).
Who is sponsoring clinical trial NCT01104402?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01104402 being conducted?
This trial has 3 study locations across Maryland, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise in Child Health
RECRUITING · NA
-
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
FEED-Cystic Fibrosis (FEED-CF)
RECRUITING · NA
-
The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes
RECRUITING · NA
-
Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic Fibrosis (CF)
RECRUITING · NA
-
Lung Transplant READY CF 2: CARING CF Ancillary RCT
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.